» Articles » PMID: 29434972

Tanshinone II is a Potent Candidate for Treatment of Lipopolysaccharide-induced Acute Lung Injury in Rat Model

Overview
Journal Oncol Lett
Specialty Oncology
Date 2018 Feb 14
PMID 29434972
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The present study aimed to investigate the effect of tanshinone II, isolated from Bunge, on lipopolysaccharide (LPS)-induced acute lung injury (ALI) in rats. Male Sprague-Dawley rats were divided into three groups: Control, LPS and tanshinone II. Animals in the tanshinone II and LPS groups were administered 10 mg/kg LPS, whereas those in the control group received an equal volume of normal saline. Tanshinone II treatment group were injected with 30 nm/kg tanshinone II at 1 h after LPS administration. The results revealed that LPS administration increased the bronchoalveolar lavage fluid protein concentration significantly compared with the control group. However, tanshinone II treatment significantly inhibited the LPS-induced increase in protein level. Treatment of the LPS-administered rats with tanshinone II prevented the formation of pulmonary edema, which was evidenced by low values for wet to dry lung weight ratio. The activity of myeloperoxidase and expression of malondialdehyde were significantly lower in lung homogenates from the tanshinone II group compared with the LPS group. Furthermore, tanshinone II treatment inhibited the expression of tumor necrosis factor-α and interleukin-6 in the blood plasma. Tissue sections of the tanshinone II group exhibited normal morphology and absence of neutrophil accumulation. However, in the LPS group, neutrophils accumulated and penetrated into the pulmonary tissues. These results suggested that tanshinone II protects the rats from LPS-induced ALI. Therefore tanshinone II may have clinical applications in the treatment of ALI.

Citing Articles

Synergistic Enhancement of Isoforskolin and Dexamethasone Against Sepsis and Acute Lung Injury Mouse Models.

Fang Y, Xiao C, Wang L, Wang Y, Zeng J, Liang Y J Inflamm Res. 2023; 16:5989-6001.

PMID: 38088941 PMC: 10712681. DOI: 10.2147/JIR.S421232.


ALCAM Deficiency Alleviates LPS-Induced Acute Lung Injury by Inhibiting Inflammatory Response.

Li R, Ren T, Zeng J, Xu H Inflammation. 2022; 46(2):688-699.

PMID: 36418761 DOI: 10.1007/s10753-022-01765-3.


Tanshinone IIA loaded bioactive nanoemulsion for alleviation of lipopolysaccharide induced acute lung injury via inhibition of endothelial glycocalyx shedding.

El-Moslemany R, El-Kamel A, Allam E, Khalifa H, Hussein A, Ashour A Biomed Pharmacother. 2022; 155:113666.

PMID: 36099790 PMC: 9466291. DOI: 10.1016/j.biopha.2022.113666.


Efficacy of terpenoids in attenuating pulmonary edema in acute lung injury: A meta-analysis of animal studies.

Wang S, Luo S, Jie J, Li D, Liu H, Song L Front Pharmacol. 2022; 13:946554.

PMID: 36034851 PMC: 9401633. DOI: 10.3389/fphar.2022.946554.


Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway.

Liao X, Gao Y, Liu J, Tao L, Xie J, Gu Y Front Oncol. 2020; 10:1756.

PMID: 33014864 PMC: 7511800. DOI: 10.3389/fonc.2020.01756.


References
1.
You H, Wei L, Sun W, Wang L, Yang Z, Liu Y . The green tea extract epigallocatechin-3-gallate inhibits irradiation-induced pulmonary fibrosis in adult rats. Int J Mol Med. 2014; 34(1):92-102. PMC: 4072398. DOI: 10.3892/ijmm.2014.1745. View

2.
Herridge M, Cheung A, Tansey C, Matte-Martyn A, Diaz-Granados N, Al-Saidi F . One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003; 348(8):683-93. DOI: 10.1056/NEJMoa022450. View

3.
Ni Y, Tian F, Lu Z, Yang G, Fu H, Wang J . Protective effect of nicotine on lipopolysaccharide-induced acute lung injury in mice. Respiration. 2010; 81(1):39-46. DOI: 10.1159/000319151. View

4.
Brandolini L, Asti C, Ruggieri V, Intilangelo A, Pellegrini L, Chiusaroli R . Lipopolysaccharide-induced lung injury in mice. II. Evaluation of functional damage in isolated parenchyma strips. Pulm Pharmacol Ther. 2000; 13(2):71-8. DOI: 10.1006/pupt.2000.0232. View

5.
Esbenshade A, Newman J, Lams P, Jolles H, Brigham K . Respiratory failure after endotoxin infusion in sheep: lung mechanics and lung fluid balance. J Appl Physiol Respir Environ Exerc Physiol. 1982; 53(4):967-76. DOI: 10.1152/jappl.1982.53.4.967. View